A Novel, Orally Active Hydrogen Sulfide-Releasing Compound, SG1002, Improves Left Ventricular Function with an Associated Induction of Angiogenesis in a Murine Model of Ischemia/Reperfusion
Hydrogen sulfide (H2S) is the newest member of the gasotransmitter family and is becoming well known for its cardioprotective effects in preclinical trials. Many recent studies have shown the benefits of exogenous H2S in the setting of acute myocardial infarction (AMI) and pressure overload-induced...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
VCU Scholars Compass
2018
|
| Subjects: | |
| Online Access: | https://scholarscompass.vcu.edu/etd/5389 https://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=6492&context=etd |